New Jersey Senate committee approves measure that would establish needle-exchange program in six cities

The New Jersey Senate Budget and Appropriations Committee on Thursday voted 8-6 to approve a compromise version of a bill (S 494) that would establish a needle-exchange program in six cities and provide $10 million to drug treatment programs in the state, the Newark Star-Ledger reports (Hester, Newark Star-Ledger, 10/13).

According to the New Jersey Department of Health and Senior Services, 14% of new HIV/AIDS cases in the state in 2005 were attributed to injection drug use.

The bill -- sponsored by state Sen. Nia Gill (D) -- would allow cities or towns to apply to the health department, which would select six cities or towns among the applicants to begin needle-exchange programs.

Officials from Atlantic City and Camden have said they are interested in establishing programs.

The amended version of the legislation would subject the programs to re-evaluation in five years.

Needle-exchange programs in the U.S. are not federally funded and are opposed by the White House Office of National Drug Control Policy (Kaiser Daily HIV/AIDS Report, 10/3).

The bill now goes to the full state Senate for consideration. According to the Star-Ledger, 21 votes are needed for the bill to pass the state Senate.

Senate President Richard Codey (D) said that the bill is "not going to pass overwhelmingly, clearly" but that "the more legislators look at it, they will see it is not what it was, and it should be much more palatable to them."

He added that the measure will receive a floor vote in December during one of the two voting sessions.

State Assembly Speaker Joseph Roberts (D), an advocate of the bill, said the lower house will vote on the bill before the end of the year (Newark Star-Ledger, 10/13).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New HIV prevention injection offers 96% protection